On the other hand, PDLIM2 is overexpressed in a variety of cancer types, including PRAD, in which it promotes cell proliferation, malignant transformation, and EMT, supporting its prooncogenic roles [9]. This evidence concerns the gene PDLIM2 and prostate adenocarcinoma.